This result is in contrast to another study using semi-quantitative analysis to measure claudin-2 expression in head and neck squamous cell carcinoma [16], which showed that lower claudin-2 levels were associated with poorer outcomes. The gene discussed is CLDN2; the disease is head and neck squamous cell carcinoma.